C. C. P. Aires

669 total citations
8 papers, 530 citations indexed

About

C. C. P. Aires is a scholar working on Pediatrics, Perinatology and Child Health, Clinical Biochemistry and Pharmacology. According to data from OpenAlex, C. C. P. Aires has authored 8 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 3 papers in Clinical Biochemistry and 3 papers in Pharmacology. Recurrent topics in C. C. P. Aires's work include Pharmacological Effects and Toxicity Studies (6 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Metabolism and Genetic Disorders (3 papers). C. C. P. Aires is often cited by papers focused on Pharmacological Effects and Toxicity Studies (6 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Metabolism and Genetic Disorders (3 papers). C. C. P. Aires collaborates with scholars based in Portugal, Netherlands and France. C. C. P. Aires's co-authors include Ronald J. A. Wanders, Isabel Tavares de Almeida, M. F. B. Silva, Lodewijk IJlst, Paula B. Luis, Jos P.N. Ruiter, M. Durán, Marinus Durán, Arno van Cruchten and Femke S. Stet and has published in prestigious journals such as The FASEB Journal, FEBS Letters and Journal of Hepatology.

In The Last Decade

C. C. P. Aires

8 papers receiving 518 citations

Peers

Countries citing papers authored by C. C. P. Aires

Since Specialization

Citations

This map shows the geographic impact of C. C. P. Aires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. C. P. Aires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. C. P. Aires more than expected).

Fields of papers citing papers by C. C. P. Aires

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. C. P. Aires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. C. P. Aires. The network helps show where C. C. P. Aires may publish in the future.

Co-authorship network of co-authors of C. C. P. Aires

This figure shows the co-authorship network connecting the top 25 collaborators of C. C. P. Aires. A scholar is included among the top collaborators of C. C. P. Aires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. C. P. Aires. C. C. P. Aires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10‐2474 2020 ·British Journal of Pharmacology ·Maria João Bonifácio, (unknown), C. C. P. Aires, Ana I. Loureiro, Carlos Fernandes‐Lopes, Nuno Pires, P. Nuno Palma, Paul Moser, Patrício Soares‐da‐Silva	8
2	EVALUATION OF THE POTENCY AND SELECTIVITY OF THE NOVEL FAAH INHIBITOR BIA 10‐2474 IN COMPARISON WITH PF‐04457845 AND JNJ‐42165279 2018 ·The FASEB Journal ·Maria João Bonifácio, (unknown), C. C. P. Aires, Ana I. Loureiro, Carlos Fernandes‐Lopes, P. Nuno Palma, Paul Moser, Patrício Soares‐da‐Silva	1
3	New insights on the mechanisms of valproate-induced hyperammonemia: Inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA 2010 ·Journal of Hepatology ·C. C. P. Aires, Arno van Cruchten, Lodewijk IJlst, Isabel Tavares de Almeida, Marinus Durán, Ronald J. A. Wanders, M. F. B. Silva	94
4	Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis 2009 ·Biochemical Pharmacology ·C. C. P. Aires, Lodewijk IJlst, Femke S. Stet, Carina Prip‐Buus, Isabel Tavares de Almeida, Marinus Durán, Ronald J. A. Wanders, M. F. B. Silva	65
5	Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes 2008 ·FEBS Letters ·C. C. P. Aires, Graça Soveral, Paula B. Luis, H.J. ten Brink, Isabel Tavares de Almeida, Marinus Durán, Ronald J. A. Wanders, M. F. B. Silva	22
6	Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review 2008 ·Journal of Inherited Metabolic Disease ·M. F. B. Silva, C. C. P. Aires, Paula B. Luis, Jos P.N. Ruiter, Lodewijk IJlst, M. Durán, Ronald J. A. Wanders, Isabel Tavares de Almeida	294
7	In vivo and in vitro studies on the interaction of valproic acid and metabolites with the leucine oxidative metabolism 2007 ·Journal of Inherited Metabolic Disease ·(unknown), Jos P.N. Ruiter, Lodewijk IJlst, C. C. P. Aires, Luísa Diogo, Patrice Garcia, Isabel Tavares de Almeida, (unknown), Jerry Vockley, R. J. A. Wanders, M. F. B. Silva	1
8	Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation 2007 ·Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Paula B. Luis, Jos P.N. Ruiter, C. C. P. Aires, Graça Soveral, Isabel Tavares de Almeida, Marinus Durán, Ronald J. A. Wanders, M. F. B. Silva	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact